These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 971329)

  • 1. Warfarin-stereochemical aspects of its metabolism by rat liver microsomes.
    Pohl LR; Nelson SD; Porter WR; Trager WF; Fasco MJ; Baker FD; Fenton JW
    Biochem Pharmacol; 1976 Oct; 25(19):2153-62. PubMed ID: 971329
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin: stereochemical aspects of its metabolism in vivo in the rat.
    Pohl LR; Bales R; Trager WF
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):233-56. PubMed ID: 981784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical biotransformation of warfarin as a probe of the homogeneity and mechanism of microsomal hydroxylases.
    Pohl LR; Porter WR; Trager WF
    Biochem Pharmacol; 1977 Jan; 26(2):109-14. PubMed ID: 836331
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of S-warfarin metabolism by nonsteroidal antiinflammatory drugs in human liver microsomes in vitro.
    Takigawa T; Tainaka H; Mihara K; Ogata H
    Biol Pharm Bull; 1998 May; 21(5):541-3. PubMed ID: 9635517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different forms of liver, kidney, and lung microsomal cytochrome P-450 by immunological inhibition of regio- and stereoselective metabolism of warfarin.
    Kaminsky LS; Fasco MJ; Guengerich FP
    J Biol Chem; 1979 Oct; 254(19):9657-62. PubMed ID: 489558
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of different forms of purified cytochrome P-450 from rat liver by immunological inhibition of regio- and stereoselective metabolism of warfarin.
    Kaminsky LS; Fasco MJ; Guengerich FP
    J Biol Chem; 1980 Jan; 255(1):85-91. PubMed ID: 7350164
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomes.
    Wheeler C; Trager WF; Porter WR
    Biochem Pharmacol; 1981 Jul; 30(13):1785-90. PubMed ID: 7271865
    [No Abstract]   [Full Text] [Related]  

  • 8. A new warfarin metabolite: structure and function.
    Fasco MJ; Dymerski PP; Wos JD; Kaminsky LS
    J Med Chem; 1978 Oct; 21(10):1054-9. PubMed ID: 722713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumene hydroperoxide-supported microsomal hydroxylations of warfarin--a probe of cytochrome P-450 multiplicity and specificity.
    Fasco MJ; Piper LJ; Kaminsky LS
    Biochem Pharmacol; 1979; 28(1):97-103. PubMed ID: 31893
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereochemical heterogeneity of hepatic UDP-glucuronosyltransferase activity in rat liver microsomes.
    Okulicz-Kozaryn I; Schaefer M; Batt AM; Siest G; Loppinet V
    Biochem Pharmacol; 1981 Jun; 30(12):1457-61. PubMed ID: 6791655
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotransformation of myrislignan by rat liver microsomes in vitro.
    Li F; Yang XW
    Phytochemistry; 2008 Feb; 69(3):765-71. PubMed ID: 17964618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K and warfarin distribution and metabolism in the warfarin-resistant rat.
    Thierry MJ; Hermodson MA; Suttie JW
    Am J Physiol; 1970 Oct; 219(4):854-9. PubMed ID: 5459483
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical applications of a quantitative high-pressure liquid chromatographic assay of warfarin and its metabolites.
    Fasco MJ; Piper LJ; Kaminsky LS
    J Chromatogr; 1977 Jan; 131():365-73. PubMed ID: 853101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic separation and assignment of absolute configuration of hydroxywarfarin isomers.
    Regalado EL; Sherer EC; Green MD; Hendersonl DW; Thomas Williamson R; Joyce LA; Welch CJ
    Chirality; 2014 Feb; 26(2):95-101. PubMed ID: 24339228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics.
    Hermans JJ; Thijssen HH
    Br J Pharmacol; 1993 Sep; 110(1):482-90. PubMed ID: 8220911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of warfarin hydroxylation catalyzed by human liver microsomes.
    Rettie AE; Eddy AC; Heimark LD; Gibaldi M; Trager WF
    Drug Metab Dispos; 1989; 17(3):265-70. PubMed ID: 2568906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ethanol on rates of elimination and metabolism of zoxazolamine, hexobarbital and warfarin sodium in the rat.
    Mallov S; Baesl TJ
    Biochem Pharmacol; 1972 Jun; 21(12):1667-78. PubMed ID: 4649128
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.
    Malátková P; Sokolová S; Chocholoušová Havlíková L; Wsól V
    Biochem Pharmacol; 2016 Jun; 109():83-90. PubMed ID: 27055738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thioacetamide-induced hepatic necrosis on the regioselective metabolism of S-warfarin by rat liver mixed-function oxidase enzymes.
    Obaseki AO; Jayaraj A; Porter WR
    Biochem Pharmacol; 1983 Aug; 32(16):2385-91. PubMed ID: 6615541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of quinidine on the 10-hydroxylation of R-warfarin: species differences and clearance projection.
    Chen Q; Tan E; Strauss JR; Zhang Z; Fenyk-Melody JE; Booth-Genthe C; Rushmore TH; Stearns RA; Evans DC; Baillie TA; Tang W
    J Pharmacol Exp Ther; 2004 Oct; 311(1):307-14. PubMed ID: 15163679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.